Regulatory Compliance

The FDA has recently notified the industry that all regenerative medicine products intended for clinical use must go through their regulatory process. Our (lab/mfg.) has worked tirelessly to abide by all FDA regulations and has recently registered a Biologic Drug Masterfile with the FDA for its MSC Exosomes. This landmark achievement makes it the only product legally permitted to be sold for clinical use through research.

Success Stories

Exosome Research

Image Description

ASC-Derived Exosomes in Combination with Hyaluronic Acid Accelerate Wound Healing Through

Image Description

Exosomes: A New Effective Non-Surgical Therapy for Androgenetic Alopecia?

Image Description

The Role of Extracellular Vesicles in Cutaneous Remodeling and Hair Follicle Dynamics